MedTrace Logo

Efficacy of Blanketrol III and Arctic Sun in Cooling Non-shivering Humans

NCT04332224 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2023-01-23

No results posted yet for this study

Summary

This study compares three medical cooling devices for effectiveness of cooling the core of non-shivering subjects. This relates to common protocols to cool patients experiencing myocardial infarctions or stokes.

Conditions

  • Body Temperature Changes

Interventions

DEVICE

Blanketrol cooling device and water-perfused blankets

Blanketrol and water-perfused blankets

DEVICE

Blanketrol and Kool Kit

Blanketrol cooling device with water-perfused vest, hood and lower body blanket

DEVICE

Arctic Sun

Arctic Sun cooling device with gel cooling pads

Sponsors & Collaborators

  • University of Manitoba

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-03-01
Primary Completion
2022-04-30
Completion
2022-04-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04332224 on ClinicalTrials.gov